1 / 16

Plenary III Ask About Aspirin

Plenary III Ask About Aspirin . Stanton Shanedling, PhD, MPH Supervisor , Heart Disease & Stroke Prevention Unit, Minnesota Department of Health . Colleagues. Alan T. Hirsch, MD

kaz
Download Presentation

Plenary III Ask About Aspirin

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Plenary IIIAsk About Aspirin Stanton Shanedling, PhD, MPH Supervisor, Heart Disease & Stroke Prevention Unit, Minnesota Department of Health

  2. Colleagues • Alan T. Hirsch, MD Professor of Medicine, Epidemiology & Community Health Director, Vascular Medicine Program, Lillehei Heart Institute, University of Minnesota - Medical School • John R. Finnegan, PhD Professor & Dean, Vice President of Public Health, University of Minnesota - School of Public Health • Russell V. Luepker, MD, MS Mayo Professor of Public Health, Division of Epidemiology &Community Health, University of Minnesota - School of Public Health • Niki Oldenburg, DrPh Research Team Leader, Vascular Medicine Program

  3. Goal: Statewide initiative to reduce CVD by promoting a community intervention to increase the appropriate use of low dose aspirin in target populations

  4. Utilize United States Preventive Services Task Force (USPSTF) aspirin recommendations for the primary prevention of cardiovascular disease: • ▪▪Encourage men age 45 to 79 years to use aspirin when the potential benefit of a reduction in myocardial infarctions outweighs the potential harm of an increase in gastrointestinal hemorrhage. (USPSTF “A” recommendation) • ▪▪Encourage women age 55 to 79 years to use aspirin when the potential benefit of reduction in ischemic strokes outweighs the potential harm of an increase in gastrointestinal hemorrhage. (USPSTF “A” recommendation)

  5. Background Baseline data prior to intervention- 2009 • 35% of men age 45-79 and 37% of women age 55-79 reported taking ASA (MN Heart Survey) • 19% of all deaths in Minnesota due to Heart Disease (18% in 2011) • 6% of all deaths in Minnesota due to Stroke (5% in 2011)

  6. Interventions to increase use of low-dose ASA 1. Health Professional Education – reaching physicians, pharmacists, nurses and other health professionals to disseminate new practice tools to improve aspirin use in the target patient population 2. Shared Media – engaging the public through the use of on-line resources to engage adherence to aspirin use; 3. Mass Media – reaching the public via use of traditional mass media, including television, newspapers, radio station, billboards, etc.

  7. Goals • Increase aspirin intake by an absolute 10% in Minnesota adult population of men age 45-79 and women age 55-79. • Reduce the number of first heart attacks and strokes in the target population in Minnesota. • Verify the impact of newly developed prevention tools and measure the effects of the campaign, in order to assure that the most effective tools can be disseminated across the State of Minnesota, as a national model.

  8. Clinic Based Interventions: Hibbing, MNThree Health Systems 1. Patient identification and activation 2. Provider and team behavior awareness and activation 3. Community Systems Change – Community Health Coordinator

  9. Public Awareness 85% liked the ads 72% found the ads engaging 95% found the ads believable 87% trusted the ads 87% had a favorable reaction

  10. Aspirin Use in Hibbing: Self-Report and Assay Results 79% 37% Before the campaign the primary prevention group rarely asked their clinician about aspirin use to prevent a heart attack or stroke (less than 1 in 5 individuals).

  11. Self-Reported Aspirin Use in the Primary Prevention Cohort This rate of change is higher than temporal trends 52% Increased aspirin use 36% ---------- Over four months aspirin use increased ---------- *Answered “daily” to the question “How often do you take aspirin”?

  12. Goals for Next 12 Months • 1. Create improved public awareness campaign messages • 2. Improve the efficacy of clinic-based ASA use intervention and metrics • > Expand use of the EHR as a tool for medication mgmt and adherence • > Achieve > 90% health professional engagement of ASA primary • prevention learning module • 3. The program is prepared to expand to a State or wider intervention in 2014

  13. Some key questions • Focus on prevention vis a vis intervention messaging? • Given ABCS why no concerted campaign to support ASA? • Ambiguity in information exchange? • Are there concerns?

  14. Contacts Alan T. Hirsch, MD hirsc005@umn.edu Stanton Shanedling, PhD, MPH stanton.shanedling@state.mn.us

  15. Plenary IIIAsk About Aspirin Q and A

More Related